Clincosm LogoSign in Get a demo

Cervical Cancer

Showing NaN - NaN of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Cervical Cancer Trial in Worldwide (Tisotumab Vedotin, Bevacizumab, Pembrolizumab)

Active, not recruiting
  • Cervical Cancer
  • Tisotumab Vedotin
  • +3 more
  • Phoenix, Arizona
  • +71 more
Jan 9, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

Recruiting
  • Advanced Solid Tumor
  • +11 more
  • Boston, Massachusetts
  • +30 more
Dec 1, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Canada, Korea,

Recruiting
  • Solid Tumor
  • +8 more
  • TBio-6517
  • Pembrolizumab
  • Phoenix, Arizona
  • +10 more
Feb 21, 2022

Quantitative Tumor Oxygen Measurements in Cervical Cancer

Active, not recruiting
  • Gynecologic Cancer
  • Cervical Cancer
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Mar 2, 2022

    Cervical Cancer, Uterine Cancer, Vaginal Cancer Trial in Boston (Image-guided brachytherapy, 3'-Deoxy-3'-18f-Fluorothymidine)

    Completed
    Has Results
    • Cervical Cancer
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Feb 8, 2022

    Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

    Completed
    Has Results
    • Gastric Adenocarcinoma
    • +15 more
    • Sacituzumab Govitecan-hziy (SG)
    • Aurora, Colorado
    • +11 more
    Aug 10, 2021

    Breast Cancer, Ovarian Cancer, Colorectal Cancer Trial in United States (Durvalumab, Tremelimumab)

    Completed
    Has Results
    • Breast Cancer
    • +4 more
    • New Haven, Connecticut
    • +5 more
    Jul 13, 2021

    Endometrial Cancer, Ovarian Cancer, Cervical Cancer Trial in Boston (temsirolimus, cediranib)

    Completed
    • Endometrial Cancer
    • +4 more
    • Boston, Massachusetts
    • +2 more
    Apr 20, 2021

    Cancer Diagnosis and Treatment on Everyday Life

    Active, not recruiting
    • Breast Cancer Female
    • +17 more
      • Aberystwyth, United Kingdom
      • +110 more
      Mar 16, 2021

      Uterine Cancer, Cervical Cancer Trial in Boston (Proton radiation therapy)

      Active, not recruiting
      • Uterine Cancer
      • Cervical Cancer
      • Proton radiation therapy
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jan 12, 2021

      Human Papilloma Virus, Cervical Cancer, Human Papillomavirus Infection Trial in Boston (WoW and BNI)

      Completed
      • Human Papilloma Virus
      • +7 more
      • WoW and BNI
      • Boston, Massachusetts
        Boston Medical Center
      Oct 8, 2019

      Cervical Cancer Trial in Boston (GSK1120212 (trametinib), GSK2141795)

      Terminated
      Has Results
      • Cervical Cancer
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      May 8, 2019

      Cervical Cancer, Endometrial Cancer Trial in Canada, United States (cisplatin, intensity-modulated radiation therapy)

      Completed
      Has Results
      • Cervical Cancer
      • Endometrial Cancer
      • Auburn, California
      • +152 more
      Feb 1, 2019

      Ovarian Cancer, Endometrial Cancer, Cervical Cancer Trial in Boston (Docetaxel, PTK787)

      Completed
      • Ovarian Cancer
      • +5 more
      • Boston, Massachusetts
      • +1 more
      Jul 26, 2018

      Cervical Cancer Trial in Boston (BNI-brief Negotiated Interview)

      Completed
      Has Results
      • Cervical Cancer
      • BNI-brief Negotiated Interview
      • Boston, Massachusetts
        Boston Medical Center
      Apr 11, 2017

      Ovarian Cancer, Cervical Cancer, Uterine Cancer Trial in Boston (communication with oncology team)

      Completed
      • Ovarian Cancer
      • +5 more
      • communication with oncology team
      • Boston, Massachusetts
        Massachusetts General Hospital
      Apr 15, 2017

      Cervical Cancer, Endometrial Cancer, Ovarian Cancer Trial in Boston (Avastin)

      Completed
      Has Results
      • Cervical Cancer
      • +4 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Feb 6, 2017

      Breast Cancer, Cervical Cancer Trial in Boston (patient Navigation)

      Completed
      • Breast Cancer
      • Cervical Cancer
      • patient Navigation
      • Boston, Massachusetts
        Boston Medical Center
      Jun 14, 2016